#11068 on the rich list of 14,644 insiders
David W. Osborne
Chief Technical Officer at Arcutis Biotherapeutics. Based in Westlake Village, California.
$7.3M
in disclosed stock, −$118K (−1.59%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 11068th of 14,644
- Companies held
- 1
- Largest holding
- ARQT, 100.0% of total
- Latest SEC filing
- Mar 6, 2023
What the $7.3M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics ARQT Common Stock | Directly | 268,854 | $27.17 | $7.3M | 100.0% | Form 4, Mar 6, 2023 |
Share counts are the amounts David W. Osborne reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 11065 | Chris Suh CHIEF FINANCIAL OFFICER, Visa. San Francisco, CA | $7.3M |
| 11066 | Thomas C. Popeck CEO, Henry Schein Products, Henry Schein. Melville, NY | $7.3M |
| 11067 | Gregory C. Toczydlowski EVP & President, Business Ins., The Travelers Companies. St. Paul, MN | $7.3M |
| 11068 | David W. Osborne Chief Technical Officer, Arcutis Biotherapeutics. Westlake Village, CA | $7.3M |
| 11069 | Daniel R. Maurer Director, CNO Financial Group. Carmel, IN | $7.3M |
| 11070 | Richard Taylor Chief Executive Officer, ONE Nuclear Energy. West Palm Beach, FL | $7.3M |
| 11071 | Robert Carilli Chief Strategy Officer, ONE Nuclear Energy. West Palm Beach, FL | $7.3M |
Other Arcutis Biotherapeutics insiders
All ARQT insiders- Bhaskar Chaudhuri$24.9MDirector. #4261 overall
- Todd Watanabe$21.1MSee Remarks. #4986 overall
- Christopher Peetz$5.2MDirector. #2841 overall
- David Topper$5.0MChief Financial Officer. #14477 overall
- Larry Todd Edwards$4.8MSee Remarks. #6612 overall
- John W. Smither$4.2MChief Financial Officer. #12736 overall
Questions
How much stock does David W. Osborne own?
David W. Osborne holds $7,304,763 in listed stock based on SEC filings and current prices, mostly Arcutis Biotherapeutics (ARQT). That ranks 11068th on the Stock Rich List.
Is this David W. Osborne's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.